Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5196)
All Articles published online
|
Publishing Process of This Article
|
Nov 30, 2018 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Transplantation
ISSN
2220-3230
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Damlaj M, Snnallah M, Alhejazi A, Ghazi S, Alahmari B, Alaskar A, Al-Zahrani M. Graft vs host disease impacts overall survival post allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia/lymphoma. World J Transplantation 2018; 8(7): 252-261 [PMID: 30596032 DOI: 10.5500/wjt.v8.i7.252] |
|---|---|
| URL: | https://www.wjgnet.com/2218-6190/full/v8/i7/252.htm |
| Number | Citing Articles |
| 1 |
Moussab Damlaj, Mohammad Snnallah, Razan Bashir, Inaam Shehab Eddine, Bader Alahmari, Hind Salama, Ahmed Alaskar, Ayman Alhejazi, Mohsen Alzahrani. Role of Allogeneic HCT as Postremission Therapy for Transplant-Eligible Adult Lymphoblastic Leukemia/Lymphoma After Frontline Hyper-CVAD. Clinical Lymphoma Myeloma and Leukemia 2020; 20(10): 690 doi: 10.1016/j.clml.2020.05.012
|
| 2 |
Ding-Ping Chen, Ying-Hao Wen, Po-Nan Wang, Ai-Ling Hour, Wei-Tzu Lin, Fang-Ping Hsu, Wei-Ting Wang. The adverse events of haematopoietic stem cell transplantation are associated with gene polymorphism within human leukocyte antigen region. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-020-79369-w
|
| 3 |
Alexandra Zanin-Zhorov, Bruce R. Blazar. ROCK2, a critical regulator of immune modulation and fibrosis has emerged as a therapeutic target in chronic graft-versus-host disease. Clinical Immunology 2021; 230: 108823 doi: 10.1016/j.clim.2021.108823
|